Literature DB >> 33322743

Serum Metabolomics Profiling of Commercially Mixed Functional Foods-Effects in Beta-Amyloid Induced Rats Measured Using 1H NMR Spectroscopy.

Nur Hasnieza Mohd Rosli1, Hanis Mastura Yahya2, Farah Wahida Ibrahim3, Suzana Shahar2, Intan Safinar Ismail4, Amalina Ahmad Azam4, Nor Fadilah Rajab2.   

Abstract

Functional foods such as pomegranate, dates and honey were shown by various previous studies to individually have a neuroprotective effect, especially in neurodegenerative disease such as Alzheimer's disease (AD). In this novel and original study, an 1H NMR spectroscopy tool was used to identify the metabolic neuroprotective mechanism of commercially mixed functional foods (MFF) consisting of pomegranate, dates and honey, in rats injected with amyloid-beta 1-42 (Aβ-42). Forty-five male albino Wistar rats were randomly divided into five groups: NC (0.9% normal saline treatment + phosphate buffer solution (PBS) solution injection), Abeta (0.9% normal saline treatment + 0.2 µg/µL Aβ-42 injection), MFF (4 mL/kg MFF treatment + PBS solution injection), Abeta-MFF (4 mL/kg MFF treatment + 0.2 µg/µL Aβ-42 injection) and Abeta-NAC (150 mg/kg N-acetylcysteine + 0.2 µg/µL Aβ-42 injection). Based on the results, the MFF and NAC treatment improved the spatial memory and learning using Y-maze. In the metabolic analysis, a total of 12 metabolites were identified, for which levels changed significantly among the treatment groups. Systematic metabolic pathway analysis found that the MFF and NAC treatments provided a neuroprotective effect in Aβ-42 injected rats by improving the acid amino and energy metabolisms. Overall, this finding showed that MFF might serve as a potential neuroprotective functional food for the prevention of AD.

Entities:  

Keywords:  1H NMR; Alzheimer’s disease; behaviour study; metabolomics; mixed functional foods

Year:  2020        PMID: 33322743      PMCID: PMC7764480          DOI: 10.3390/nu12123812

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  68 in total

1.  Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk.

Authors:  Fabian Corlier; George Hafzalla; Joshua Faskowitz; Lewis H Kuller; James T Becker; Oscar L Lopez; Paul M Thompson; Meredith N Braskie
Journal:  Neuroimage       Date:  2018-01-28       Impact factor: 6.556

Review 2.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.

Authors:  Claudine Manach; Gary Williamson; Christine Morand; Augustin Scalbert; Christian Rémésy
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

Review 3.  Memory loss in Alzheimer's disease: implications for development of therapeutics.

Authors:  Carl A Gold; Andrew E Budson
Journal:  Expert Rev Neurother       Date:  2008-12       Impact factor: 4.618

Review 4.  Recent advances in the application of metabolomics to Alzheimer's Disease.

Authors:  Eugenia Trushina; Michelle M Mielke
Journal:  Biochim Biophys Acta       Date:  2013-06-29

5.  Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model.

Authors:  Edoardo Parrella; Tom Maxim; Francesca Maialetti; Lu Zhang; Junxiang Wan; Min Wei; Pinchas Cohen; Luigi Fontana; Valter D Longo
Journal:  Aging Cell       Date:  2013-03-11       Impact factor: 9.304

6.  The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis.

Authors:  Homa Rasoolijazi; Mohammad Taghi Joghataie; Mehrdad Roghani; Maliheh Nobakht
Journal:  Iran Biomed J       Date:  2007-10

Review 7.  Mitochondrial ATP synthase: architecture, function and pathology.

Authors:  An I Jonckheere; Jan A M Smeitink; Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2011-08-27       Impact factor: 4.982

8.  Effects of Clinacanthus nutans leaf extract on lipopolysaccharide -induced neuroinflammation in rats: A behavioral and 1H NMR-based metabolomics study.

Authors:  Amalina Ahmad Azam; Intan Safinar Ismail; Mohd Farooq Shaikh; Khozirah Shaari; Faridah Abas
Journal:  Avicenna J Phytomed       Date:  2019 Mar-Apr

9.  1HNMR-based metabolomic profile of rats with experimental acute pancreatitis.

Authors:  Juan Li; Xian-lin Zhao; Yi-xia Liu; Xiao-hang Peng; Shi-feng Zhu; Hui Guo; Yi-ling Liu; Mei-hua Wan; Wen-fu Tang
Journal:  BMC Gastroenterol       Date:  2014-06-30       Impact factor: 3.067

Review 10.  Application of Metabolomics in Alzheimer's Disease.

Authors:  Jordan Maximillian Wilkins; Eugenia Trushina
Journal:  Front Neurol       Date:  2018-01-12       Impact factor: 4.003

View more
  1 in total

1.  Preventive Impact of Long-Term Ingestion of Chestnut Honey on Glucose Disorders and Neurodegeneration in Obese Mice.

Authors:  Simona Terzo; Pasquale Calvi; Domenico Nuzzo; Pasquale Picone; Giacoma Galizzi; Luca Caruana; Marta Di Carlo; Laura Lentini; Roberto Puleio; Flavia Mulè; Antonella Amato
Journal:  Nutrients       Date:  2022-02-11       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.